Jardiance Cost in Utah 2026: Prices, Medicaid, Insurance, and Compounded Options

What Is the Cash Price for Jardiance in Utah in 2026?

The average cash price for brand-name Jardiance at Utah retail pharmacies sits at approximately $680 per month in 2026, matching the Boehringer Ingelheim and Eli Lilly manufacturer list price. No FDA-approved generic is currently on the market. That figure can vary by $20 to $40 depending on the pharmacy, but GoodRx and similar coupon aggregators rarely drop it below $600 without manufacturer assistance.

Empagliflozin is an SGLT2 inhibitor approved by the FDA for multiple indications. The Jardiance prescribing label on the FDA's database documents the approved doses of 10 mg and 25 mg once daily for type 2 diabetes, 10 mg once daily for heart failure with reduced ejection fraction, 10 mg once daily for chronic kidney disease, and 10 mg once daily for heart failure with preserved ejection fraction [1]. Each additional indication added since the original 2014 approval has expanded clinical demand without reducing the list price.

For a patient paying entirely out of pocket, a 90-day supply may approach $2,000 at full retail. That figure is why understanding every available assistance program matters before a prescription is filled.

Why list price and actual price diverge so sharply. Pharmacy benefit managers negotiate rebates that flow back to insurers, not patients. Cash-pay customers absorb the full list price. A 2022 analysis in JAMA Health Forum found that SGLT2 inhibitor list prices rose 35% between 2014 and 2021 while net-of-rebate prices rose only 13%, illustrating the gap [2]. Uninsured Utahns get no share of those rebates.

Does Utah Medicaid Cover Jardiance?

Utah Medicaid does not cover Jardiance for type 2 diabetes, heart failure, or chronic kidney disease as a standard formulary benefit in 2026. Prior-authorization pathways exist for some SGLT2 inhibitors in other states, but Utah's fee-for-service Medicaid program has not added empagliflozin to its preferred drug list.

Medicaid managed care plans contracted through Utah (including Select Health Community Care and Molina Healthcare of Utah) follow similar formulary restrictions. A patient may file a formulary exception or prior-authorization request citing the 2023 American Diabetes Association Standards of Care, which place SGLT2 inhibitors with proven cardiovascular or renal benefit as preferred agents regardless of HbA1c [3]. Approval is not guaranteed, but documented cardiovascular disease or stage 3 or 4 CKD strengthens the clinical argument.

The practical reality: most Utah Medicaid beneficiaries will need to pursue the manufacturer savings program or a compounded alternative. A prescribing clinician can write a letter of medical necessity to support prior authorization, particularly for patients with established heart failure or an eGFR between 20 and 45 mL/min/1.73 m2, the population in which EMPEROR-Reduced and EMPA-KIDNEY showed the largest absolute benefit [4].

How Does the Boehringer Ingelheim and Lilly Savings Card Work in Utah?

Commercially insured patients in Utah who are not on a government program (Medicaid, Medicare Part D, or CHIP) can enroll in the Jardiance Savings Card through Boehringer Ingelheim and Eli Lilly. Eligible patients pay as little as $10 per month, and the card covers up to $150 per fill for a maximum of 12 fills per year.

Enrollment takes about five minutes at the manufacturer's website or through a telehealth platform that prescribes it. The savings card does not apply to Medicare Part D, Medicaid, or any other federal or state government program. Utah patients on Medicare will need to rely on the Extra Help (Low Income Subsidy) program, their Part D plan's negotiated price, or a patient-assistance program from the manufacturer for free drug.

Boehringer Ingelheim's patient assistance program, called "myBI Support," provides Jardiance at no cost to uninsured patients whose household income falls at or below 400% of the federal poverty level. Applications require proof of income and a prescriber's signature. Processing typically takes two to four weeks.

Is Compounded Empagliflozin Legal in Utah?

Compounded empagliflozin prepared by a state-licensed 503A compounding pharmacy is legal in Utah. Under Section 503A of the Federal Food, Drug, and Cosmetic Act, a licensed pharmacist may compound a drug product that is not commercially available in the needed strength, dosage form, or combination, provided it is dispensed pursuant to a valid patient-specific prescription [5].

Empagliflozin is commercially available as brand-name Jardiance, so the clinical justification typically centers on a documented medical need for a different dose, a specific excipient-free formulation for allergy purposes, or a cost barrier that makes the commercial product inaccessible. Prescribers should document the rationale in the medical record.

503B outsourcing facilities, which operate under FDA oversight and compound in bulk without patient-specific prescriptions, are not currently permitted to compound empagliflozin because the drug is not on the FDA's 503B bulks list. Only 503A pharmacies, compounding for individual patients, can legally prepare empagliflozin in Utah.

The HealthRX 503A Access Framework for Utah Empagliflozin Patients. When evaluating whether a patient qualifies for compounded empagliflozin through a Utah 503A pharmacy, the HealthRX medical team uses a three-step clinical screen: (1) Confirm the patient has a valid diagnosis matching an FDA-approved empagliflozin indication (type 2 diabetes, heart failure, or CKD). (2) Document the specific reason the commercial product does not meet the patient's clinical or financial needs. (3) Verify the compounding pharmacy holds a current Utah Division of Occupational and Professional Licensing (DOPL) pharmacy license and that the compounding pharmacist signs a compounding record per USP 795 standards. Patients who clear all three steps are appropriate candidates for a 503A prescription.

Cost at a licensed Utah 503A pharmacy can range from near $0 (when dispensed through a HealthRX-affiliated pharmacy partner as part of a membership program) to roughly $50 to $80 per month for standard empagliflozin capsules. That compares favorably with the $680 retail price of brand-name Jardiance.

Quality considerations. Compounded products are not subject to FDA pre-market approval. Purity, potency, and sterility depend on the pharmacy's adherence to USP Chapter 795 guidelines for non-sterile compounding. Patients should ask the pharmacy for a certificate of analysis from an accredited third-party laboratory before starting therapy.

Which Commercial Insurance Plans Cover Jardiance in Utah?

Most major commercial insurance carriers active in Utah include empagliflozin on their formularies, though tier placement and cost-sharing vary significantly.

Select Health (Intermountain's insurance arm, Utah's largest commercial carrier) places Jardiance on Tier 3 or Tier 4 depending on the plan year. A typical Tier 3 co-pay after deductible runs $60 to $90 per 30-day supply; Tier 4 specialty tier co-pays can reach $150 or more. The Boehringer Ingelheim savings card can offset this co-pay for eligible members.

PEHP (Public Employees Health Program), which covers Utah state employees, covers Jardiance with a prior authorization requirement for the cardiovascular or renal indications, waived if the patient's chart documents an LVEF below 40% or an eGFR below 45 mL/min/1.73 m2.

Regence BlueCross BlueShield of Utah covers Jardiance on Tier 3 with a quantity limit of 30 tablets per 30-day supply. United Healthcare and Aetna plans sold through the Utah exchange (Healthcare.gov) list empagliflozin on Tier 3 with co-pays ranging from $45 to $120 after deductible, depending on the metal tier of the plan.

Medicare Part D plans in Utah, including AARP/UnitedHealthcare Walgreens Rx, Humana Walmart Value Rx, and SilverScript, vary widely. The average beneficiary cost-sharing for Jardiance under Part D dropped modestly following the Inflation Reduction Act's cap on out-of-pocket drug spending at $2,000 per year starting in 2025, but monthly costs can still reach $50 to $100 for patients in the coverage gap.

Calling your plan's pharmacy benefits number before filling the prescription takes ten minutes and can save hundreds of dollars. Ask specifically about step-therapy requirements; some Utah plans require a trial of metformin plus one other generic diabetes agent before approving Jardiance without prior authorization.

Why Empagliflozin Is Prescribed: The Clinical Evidence

Empagliflozin's price would be easier to dismiss if the clinical evidence were marginal. It is not.

EMPA-REG OUTCOME enrolled 7,020 patients with type 2 diabetes and established cardiovascular disease and randomized them to empagliflozin 10 mg or 25 mg versus placebo on top of standard care. At a median follow-up of 3.1 years, the drug reduced the composite of cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke by 14% (hazard ratio 0.86 to 95% CI 0.74 to 0.99, P<0.001 for noninferiority; P=0.04 for superiority). Cardiovascular death alone dropped by 38% [6]. Those numbers are from a hard-outcome randomized controlled trial, not a surrogate endpoint study, which is why cardiologists and endocrinologists push hard for access.

EMPEROR-Reduced (N=3,730) established empagliflozin 10 mg as a standard-of-care agent in heart failure with reduced ejection fraction, cutting the composite of CV death or worsening heart failure by 25% (HR 0.75 to 95% CI 0.65 to 0.86, P<0.001) [4]. The 2022 ACC/AHA Heart Failure Guidelines give SGLT2 inhibitors a Class I, Level of Evidence A recommendation for patients with HFrEF [7].

EMPA-KIDNEY (N=6,609) confirmed benefit in CKD, reducing the composite of kidney disease progression or CV death by 28% (HR 0.72 to 95% CI 0.64 to 0.82, P<0.001) across a broad eGFR range down to 20 mL/min/1.73 m2 [8].

These are the trials clinicians cite when writing prior-authorization letters to Utah insurance plans. Knowing them helps patients understand why their provider considers access a medical, not merely a convenience, issue.

As the 2023 ADA Standards of Care state directly: "In patients with type 2 diabetes and established cardiovascular disease or indicators of high cardiovascular risk, established kidney disease, or heart failure, an SGLT2 inhibitor with proven benefit is recommended as part of the glucose-lowering regimen independent of HbA1c" [3].

Can a Utah Patient Get a Jardiance Prescription via Telehealth?

Yes. Utah law permits telehealth prescribing of non-controlled medications, including empagliflozin, following a valid patient-physician relationship established through a synchronous audio-video encounter. The Utah Telehealth Act (Utah Code Ann. Section 26B-4-401 et seq.) does not require an in-person visit before a prescription for a non-scheduled medication can be issued.

A telehealth visit for Jardiance typically involves a review of the patient's diabetes history, HbA1c, renal function panel (eGFR and urine albumin-to-creatinine ratio), current medications, blood pressure, and cardiovascular history. The whole evaluation usually takes 20 to 30 minutes. Prescriptions can be sent electronically to any licensed Utah pharmacy or to a licensed 503A compounding pharmacy.

HealthRX providers are licensed in Utah and can evaluate, prescribe, and coordinate pharmacy fulfillment in a single encounter. Patients should bring or upload recent lab work, ideally a comprehensive metabolic panel and HbA1c drawn within the past 90 days, to speed the visit.

One practical note: empagliflozin should not be started in patients with an eGFR below 20 mL/min/1.73 m2 for glycemic control, though the CKD indication in EMPA-KIDNEY extended to lower eGFR values for cardiorenal protection. A telehealth provider will check this before prescribing.

What Are the Side Effects Utahns Should Know Before Starting?

Understanding the risk profile helps patients manage therapy correctly and avoid unnecessary discontinuation.

Genital mycotic infections occur in roughly 6% to 8% of women and 3% to 4% of men taking empagliflozin, compared with about 2% with placebo, based on pooled phase III data [1]. These are generally mild and respond to standard antifungal treatment. Good hygiene reduces recurrence.

Diabetic ketoacidosis (DKA) is a rare but serious risk, occurring in approximately 0.1% of patients per year in clinical trials. The risk rises with very-low-carbohydrate diets, prolonged fasting, or major surgery. The FDA recommends holding empagliflozin at least three days before elective procedures [1].

Urinary tract infections, volume depletion, and modest LDL increases (mean 2.1 mg/dL in EMPA-REG OUTCOME) are other noted effects [6]. Fournier's gangrene (necrotizing fasciitis of the genitalia) has been reported in fewer than one per million patient-years across all SGLT2 inhibitors, prompting an FDA label warning but not a black-box warning.

Blood pressure drops modestly, typically 2 to 3 mmHg systolic, which benefits most patients with diabetes but may require dose adjustment of antihypertensive agents in patients with systolic BP below 110 mmHg.

What Is the Cheapest Way for a Utah Patient to Get Empagliflozin in 2026?

The answer depends on insurance status.

Commercially insured: Use the Boehringer Ingelheim / Lilly savings card. Out-of-pocket drops to as low as $10 per month. If the plan places Jardiance on a high tier, appeal for a lower tier or request a formulary exception.

Uninsured or underinsured, income <400% FPL: Apply to Boehringer Ingelheim's myBI Support patient assistance program for free brand-name Jardiance. Expect two to four weeks for processing.

Uninsured, need therapy faster or at steady low cost: A Utah-licensed 503A compounding pharmacy can prepare empagliflozin capsules. Costs range from near zero (through a HealthRX membership plan) to $50 to $80 per month, compared with $680 for brand Jardiance.

Medicare Part D: Explore Extra Help / Low Income Subsidy eligibility through the Social Security Administration. The $2,000 annual out-of-pocket cap under the Inflation Reduction Act also limits total exposure starting in 2025.

All patients: GoodRx and RxSaver coupons rarely bring brand Jardiance below $600 at Utah pharmacies, so manufacturer and compounding routes are more reliable cost-reduction strategies.